Benign neoplasm of prostate

Summary

Benign neoplasm of prostate (MONDO:0021510) is a cancer. A subtype of benign male reproductive system neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	benign neoplasm of prostate
Mondo ID	MONDO:0021510
ICD-10-CM	D29.1
ICD-11	1144614287
NCIT	C3613
SNOMED CT	92308005
UMLS	C0154009
MedGen	57577
Anatomy (UBERON)	UBERON:0002367
Is cancer (heuristic)	yes

Also known as: benign neoplasm of the prostate · benign prostate neoplasm · benign prostate tumor · benign prostate tumour · benign prostatic neoplasm · benign tumor of prostate · benign tumor of the prostate · benign tumour of prostate · benign tumour of the prostate · prostate gland benign neoplasm

Disease family

This is a subtype of benign male reproductive system neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › benign neoplasm › benign reproductive system neoplasm › benign male reproductive system neoplasm › benign neoplasm of prostate

Related subtypes (5): lipoma of spermatic cord, benign neoplasm of testis, benign neoplasm of penis, benign neoplasm of scrotum, benign neoplasm of epididymis

Subtypes (4): prostatic adenoma, benign prostate phyllodes tumor, prostate leiomyoma, fibroma of prostate

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.